Company profile · Biotech & medical
TAHO Pharmaceuticals
泰合生技藥品股份有限公司 · 6467
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
TAHO Pharma develops new drug formulations using its proprietary Transepithelial Delivery System platform, including transdermal patches, oral dissolving films, and buccal films.[1]
The company's product line covers antithrombotic drugs, opioid overdose antidotes, ADHD treatments, and chemotherapy anti-emetic products.[2]
Its chemotherapy anti-emetic oral dissolving film product has been approved and launched in Japan.[3]
Next week's investor conferences, ex-dividend dates and shareholder meetings, only in the email. Every listed Taiwan company reports its November sales by 10 Dec. The free Friday email on 11 Dec has the summary: which supply-chain groups grew and which shrank.
After subscribing, check your inbox (and spam folder) and confirm your subscription. We do this to protect you from spammers.
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$0m | – | -99.2% |
2024-12 to 2026-10, monthly revenue.
Foreign investors
| Last 17 trading days | Net |
|---|---|
| 2026-10-20 to 2026-11-13 | +NT$419m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | TAHO Pharmaceuticals Ltd. |
|---|---|
| Chinese name | 泰合生技藥品股份有限公司 |
| Stock code | 6467 (TWSE) |
| Industry | Biotech & medical |
| Founded | 07 Jul 2010 |
| Listed | 20 Oct 2026 |
| Paid-in capital | NT$599m |
| Chairman | 李世仁 |
| President | 李世仁 |
| Headquarters | 3F, No.550, Ruiguang Road, Taipei 114, Taiwan |
| Website | https://www.tahopharma.com |
| Official business description | 新劑型藥物(505b(2)NDA)開發 · 透皮及透黏膜藥物傳輸平台技術 |
Facts from MOPS company basic information, retrieved 12 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- MOPS 公司基本資料 泰合生技藥品股份有限公司 · mops · retrieved 12 Nov 2026
- 關於泰合-泰合生技藥品股份有限公司 · website · retrieved 12 Nov 2026
- 泰合生技CDO業務持續認列營收 委託開發進展順利 (股票代碼6467)-泰合生技藥品股份有限公司 · website · retrieved 12 Nov 2026
Using it at work? Join the team-plan waiting list
After subscribing, check your inbox (and spam folder) and confirm your subscription. We do this to protect you from spammers.